RxDoctor Payments Data

Laurie Thornton

Family · Hazlehurst, MSNPI 1609071265

Payments from drug & device makers

$1,137in general payments, 2019–2025

Across 70 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$179
  • Novo Nordisk$151
  • Lilly USA, LLC$144
  • GSK$135
  • Boehringer Ingelheim$106
  • AstraZeneca$72
  • plus $350 from 12 others

What the payments were for

  • Food & beverage$1,137100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,137 in reported general payments places this provider in the 70th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$27,085
Medicare patients
205
Services billed
1,042

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide26$32,574
TrulicityDulaglutide11$14,853
JardianceEmpagliflozin13$12,491
Cefdinir22$625
Albuterol Sulfate HfaAlbuterol Sulfate12$558
Fluticasone Propionate44$468
Atorvastatin Calcium37$440
Olmesartan Medoxomil12$417
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst20$341
Estradiol14$276
Triamcinolone Acetonide12$271
Omeprazole19$266
Losartan Potassium17$198
Doxycycline Hyclate20$192
Fluconazole27$183

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$151$32,57426 claims
Lilly USA, LLCTrulicity$144$14,85311 claims
Boehringer IngelheimJardiance$106$12,49113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,007 family providers in Mississippi.

Other family in Hazlehurst

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →